Offering women a new approach to HIV prevention
Offering Women PrEP With Education and Shared Decision-making (Aim 2)
This study is trying a new way to help women, especially women of color, access HIV prevention medication more easily by using a tablet tool to educate them and training clinics to provide better support.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 366 (estimated) |
| Ages | 18 Years to 45 Years |
| Sex | All |
| Sponsor | University of California, San Francisco Academic / other |
| Locations | 1 site (Jacksonville, Florida) |
| Trial ID | NCT05619497 on ClinicalTrials.gov |
What this trial studies
This study aims to improve access to pre-exposure prophylaxis (PrEP) for cisgender women, particularly women of color, by addressing barriers to its implementation. It involves a patient- and clinic-level intervention at a public health family planning clinic in Duval County, Florida, which has a high incidence of HIV among women. The intervention includes a tablet-based decision support tool to educate users about HIV vulnerabilities and prevention strategies, along with clinic-wide training on shared decision making and trauma-informed care. The goal is to enhance knowledge and reduce stigma around HIV prevention methods, ultimately increasing PrEP uptake among eligible women.
Who should consider this trial
Good fit: Ideal candidates for this study are women aged 18 to 45 who self-identify as women, are English-speaking, and are not known to be living with HIV.
Not a fit: Patients who are currently using PrEP or those assigned male at birth who self-identify as men will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly increase the number of women who access and utilize PrEP, thereby reducing HIV transmission rates.
How similar studies have performed: Other studies have shown success in improving PrEP uptake through targeted interventions, but this specific approach focusing on women of color is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Self-identify as a woman (regardless of pregnancy status) * Age 18 years - 45 years * Not known to be living with HIV (based on self-report) * English speaking * Interested in participating in the study Exclusion Criteria: * Unable to consent * Currently using PrEP * Those who were assigned male at birth and self-identify as a man * Unwilling to be contacted in 3 months
Where this trial is running
Jacksonville, Florida
- Florida Department of Health, Duval County — Jacksonville, Florida, United States (Recruiting)
Study contacts
- Principal investigator: Christine Dehlendorf, MD, MAS — University of California, San Francisco
- Study coordinator: Whitney Wilson, MPH
- Email: whitney.wilson@ucsf.edu
- Phone: 628-206-4048
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.